🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Trastuzumab - Medicines in Ireland

19 authorised products containing Trastuzumab, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 19 authorised medicines
MedicineActive substanceLicence holderStatus
Dazublys 150 mg powder for concentrate for solution for infusion
EU/1/25/1949/001
 Trastuzumab Curateq Biologics s.r.o. —
Herceptin 150 mg powder for concentrate for solution for infusion
EU/1/00/145/001
 Trastuzumab Roche Registration GmbH —
Herceptin 600 mg solution for injection in vial
EU/1/00/145/002
 Trastuzumab Roche Registration GmbH —
Herwenda 150 mg powder for concentrate for solution for infusion
EU/1/23/1762/001
 Trastuzumab Sandoz GmbH —
Herzuma 150 mg powder for concentrate for solution for infusion
EU/1/17/1257/001
 Trastuzumab Celltrion Healthcare Hungary Kft. —
Herzuma 420 mg powder for concentrate for solution for infusion
EU/1/17/1257/002-003
 Trastuzumab Celltrion Healthcare Hungary Kft. —
KANJINTI 150 mg powder for concentrate for solution for infusion
EU/1/18/1281/001
 Trastuzumab Amgen Europe B.V. —
KANJINTI 420 mg powder for concentrate for solution for infusion
EU/1/18/1281/002
 Trastuzumab Amgen Europe B.V. —
Ogivri 150 mg powder for concentrate for solution for infusion
EU/1/18/1341/001
 Trastuzumab Biosimilar Collaborations Ireland Limited —
Ogivri 420 mg powder for concentrate for solution for infusion
EU/1/18/1341/002
 Trastuzumab Biosimilar Collaborations Ireland Limited —
Ontruzant 150 mg Powder for concentrate for solution for infusion
EU/1/17/1241/001
 Trastuzumab Samsung Bioepis NL B.V. —
Phesgo 1200 mg/600 mg solution for injection
EU/1/20/1497/001
 Pertuzumab, Trastuzumab Roche Registration GmbH —
Phesgo 600 mg/600 mg solution for injection
EU/1/20/1497/002
 Pertuzumab, Trastuzumab Roche Registration GmbH —
Trazimera 150 mg powder for concentrate for solution for infusion
EU/1/18/1295/001
 Trastuzumab Pfizer Europe MA EEIG —
Tuznue 150 mg Powder for concentrate for solution for infusion
EU/1/24/1864/001
 Trastuzumab Prestige Biopharma Belgium —
Tuznue 420 mg Powder for concentrate for solution for infusion
EU/1/24/1864/002
 Trastuzumab Prestige Biopharma Belgium —
Zercepac 150 mg Powder for concentrate for solution for infusion
EU/1/20/1456/001
 Trastuzumab Accord Healthcare S.L.U. —
Zercepac 420 mg powder for concentrate for solution for infusion
EU/1/20/1456/003
 Trastuzumab Accord Healthcare S.L.U. —
Zercepac 60 mg powder for concentrate for solution for infusion
EU/1/20/1456/002
 Trastuzumab Accord Healthcare S.L.U. —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.